Pfizer Inc. (PFE) Social Stream
PFIZER INC (PFE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PFIZER INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 11 | $61 | $41 | $47.6 | $49.57 | -3.97% |
| 2021-11-14 | 10 | $61 | $41 | $47.6 | $49.57 | -3.97% |
| 2021-11-19 | 11 | $61 | $41 | $48.727 | $49.57 | -1.7% |
| 2021-11-23 | 11 | $61 | $41 | $50.09 | $49.57 | 1.05% |
| 2021-11-29 | 11 | $61 | $41 | $51.09 | $49.57 | 3.07% |
| 2021-12-09 | 13 | $61 | $41 | $52.666 | $49.57 | 6.25% |
| 2021-12-14 | 14 | $61 | $41 | $54.642 | $49.57 | 10.23% |
| 2021-12-15 | 14 | $61 | $41 | $55.214 | $49.57 | 11.39% |
| 2021-12-17 | 13 | $75 | $41 | $56.214 | $49.57 | 13.4% |
| 2022-01-04 | 13 | $75 | $41 | $57.571 | $49.57 | 16.14% |
| 2022-01-05 | 13 | $75 | $41 | $58.357 | $49.57 | 17.73% |
| 2022-01-24 | 12 | $75 | $41 | $58.923 | $49.57 | 18.87% |
| 2022-01-28 | 12 | $75 | $41 | $59.23 | $49.57 | 19.49% |
| 2022-02-09 | 12 | $75 | $44 | $60.75 | $49.57 | 22.55% |
| 2022-04-22 | 12 | $75 | $44 | $61.181 | $49.57 | 23.42% |
| 2022-05-02 | 12 | $75 | $44 | $60.666 | $49.57 | 22.38% |
| 2022-05-04 | 12 | $75 | $44 | $59.833 | $49.57 | 20.7% |
| 2022-05-14 | 12 | $75 | $44 | $59.583 | $49.57 | 20.2% |
| 2022-06-15 | 12 | $75 | $44 | $59.23 | $49.57 | 19.49% |
| 2022-06-22 | 12 | $75 | $52 | $60.5 | $49.57 | 22.05% |
| 2022-07-29 | 12 | $75 | $49 | $59.416 | $49.57 | 19.86% |
| 2022-08-25 | 12 | $75 | $49 | $59.25 | $49.57 | 19.53% |
| 2022-10-05 | 12 | $75 | $49 | $58.833 | $49.57 | 18.69% |
| 2022-10-12 | 12 | $75 | $48 | $57.833 | $49.57 | 16.67% |
| 2022-10-13 | 12 | $75 | $44 | $57.25 | $49.57 | 15.49% |
| 2022-11-01 | 12 | $75 | $44 | $56.833 | $49.57 | 14.65% |
| 2022-11-02 | 12 | $75 | $44 | $56.75 | $49.57 | 14.48% |
| 2022-11-03 | 12 | $75 | $49 | $57.333 | $49.57 | 15.66% |
The Trend in the Analyst Price Target
PFE's average price target has moved up $9.49 over the prior 51 weeks.
Over the past 48 weeks, PFE's average upside potential has been 17.25%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-16 | 12 | 75 | 44 | 60.666 | 52.92 | 14.64% |
| 2022-09-10 | 12 | 75 | 49 | 58.833 | 47.84 | 22.98% |
| 2022-09-17 | 12 | 75 | 49 | 58.833 | 46.03 | 27.81% |
| 2022-10-13 | 12 | 75 | 44 | 57.250 | 42.98 | 33.2% |
| 2022-11-03 | 11 | 75 | 49 | 57.333 | 46.57 | 23.11% |
PFE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 8 | 0 | 4 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 25 months, PFE's average broker recommendation rating improved by 0.55.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of Pharmaceutical Products stocks, PFIZER INC's upside potential (average analyst target price relative to current price) is higher than 400.57% of them.
- PFIZER INC's average analyst price target is greater than 420.53% of stocks in the mega market cap category.
- In terms of how PFIZER INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 2711.74% of that group.
- PFIZER INC's variance in analysts' estimates is lower than -981.57% of Pharmaceutical Products stocks.
Stocks similar to PFIZER INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LLY, ABT, and BNTX.
View All Top Stocks by Price Target
Is PFE a Buy, Hold or Sell? See the POWR Ratings now!